JavaScript is disabled for your browser. Some features of this site may not work without it.
eCommons user survey
In anticipation of a significant software upgrade, the eCommons team invites you to participate in a brief survey.
In anticipation of a significant software upgrade, the eCommons team invites you to participate in a brief survey.
2019 CVM News: Cancer and SIRT5
Other Titles
2019 CVM News: Weiss, Cerione to study the detailed molecular functions of SIRT5 in cancer cells with $1.95M NIH grant
Abstract
This news item from Cornell Research is about: New anticancer agents are in great demand due to the heterogeneous nature of cancer and the development of resistance to existing drugs. This collaborative research with Robert Weiss, Biomedical Sciences, Richard Cerione, Molecular Medicine, and Hening Lin, Chemistry and Chemical Biology, aims to establish SIRT5 inhibition as new strategy to treat cancers.
Date Issued
2019-05-30Publisher
Cornell University. College of Veterinary Medicine
Subject
Cornell University. College of Veterinary Medicine -- Periodicals.; Weiss, Robert; Cerione, Richard; Cornell Research
Type
article